The FDA today reported that so far, it has found no signs of heart risks associated with long-term use of the drugs Prilosec and Nexium. disease (GERD) and stomach and duodenal ulcers. Prilosec is ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration warned today that patients taking the ...

Background: On May 29, 2007 AstraZeneca, the maker of Prilosec (omeprazole) and Nexium (esomeprazole), sent FDA data from two long-term studies in patients with severe gastroesophageal reflux disease ...

A recent article in The New York Times sheds light on a little known problem: A class of drugs used to prevent heartburn may reduce the body s ability to absorb essential nutrients. Studies show that ...

(RTTNews) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The ...

What seemed like a scary possible connection between the blockbuster heartburn drugs Nexium and Prilosec and heart attacks appears to be a false alarm, experts assure us. The reappearance of these ...

Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company’s heartburn medications Nexium and Prilosec. File ...

FDA officials say it will need three months to thoroughly analyze data on possible cardiac risk associated with Nexium and Prilosec, both proton pump inhibitors used to treat heartburn and reflux ...

A federal judicial panel has transferred more than 200 cases to New Jersey involving heartburn medications Nexium and Prilosec just six months after it refused a similar request. In a notably lengthy ...

CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...

Pharmaceutical companies usually provide innovation that helps improve the lives of patients. But AstraZeneca marketed Nexium, a drug that should have never been approved in the first place. The ...

LOS ANGELES Extreme complications from Type 1 diabetes and renal failure put 55-year-old Danny Parr in the hospital. But medical exams revealed he also has significant coronary artery disease, so he's ...